Cocrystal Pharma Inc (COCP)

Jul 05, 2026

COCPCocrystal Pharma Inc Dividends - Finviz

Jul 05, 2026

Jun 26, 2026

Enterprise value to revenue forward of Cocrystal Pharma, Inc. – NASDAQ:COCP - TradingView

Jun 26, 2026

Jun 26, 2026

Price to earnings forward of Cocrystal Pharma, Inc. – NASDAQ:COCP - TradingView

Jun 26, 2026

Jun 26, 2026

Price to sales forward of Cocrystal Pharma, Inc. – NASDAQ:COCP - TradingView

Jun 26, 2026

Jun 26, 2026

Price to book forward of Cocrystal Pharma Inc – LS:A3DWYX - TradingView

Jun 26, 2026

Jun 26, 2026

Cocrystal Pharma Inc Actuals & Estimates (NASDAQ:COCP) - TradingView

Jun 26, 2026

Jun 26, 2026

Cocrystal Pharma(COCP) Stock Options Chain | Quotes & News - Moomoo

Jun 26, 2026

Jun 26, 2026

COCP Forecast — Price Target — Prediction for 2027 - TradingView

Jun 26, 2026

Jun 26, 2026

8CC Forecast — Price Target — Prediction for 2027 - TradingView

Jun 26, 2026

Jun 24, 2026

Cocrystal Pharma Inc (COCP) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 24, 2026

Jun 23, 2026

Cocrystal Pharma Company Profile & Introduction - Moomoo

Jun 23, 2026

Jun 19, 2026

Cocrystal Pharma Inc (COCP) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 19, 2026

Jun 18, 2026

Cocrystal Pharma Inc (COCP) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jun 18, 2026

Jun 18, 2026

Cocrystal Pharma Inc (COCP) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 18, 2026

Jun 18, 2026

Cocrystal Pharma Inc (COCP) Institutional Confidence - TradingKey

Jun 18, 2026

Jun 18, 2026

Cocrystal Pharma Inc (COCP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jun 18, 2026

Jun 18, 2026

Cocrystal Pharma Inc (COCP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 18, 2026

Jun 17, 2026

Cocrystal Pharma Inc (COCP) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 17, 2026

Jun 17, 2026

Cocrystal Pharma Inc (COCP) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jun 17, 2026

Jun 10, 2026

Cocrystal Pharma Appoints New CEO to Lead Transition - The Globe and Mail

Jun 10, 2026

Jun 09, 2026

Cocrystal Pharma Appoints James Sapirstein as New CEO – Leadership Transition and Company Details - Minichart

Jun 09, 2026

Jun 09, 2026

Cocrystal Pharma appoints James Sapirstein as CEO with new compensation package By Investing.com - Investing.com South Africa

Jun 09, 2026

Jun 09, 2026

Cocrystal Pharma appoints James Sapirstein as CEO with new compensation package - Investing.com India

Jun 09, 2026

Jun 09, 2026

James Sapirstein becomes CEO of Cocrystal Pharma (NASDAQ: COCP) - Stock Titan

Jun 09, 2026

Jun 05, 2026

COCP Q1 2026 Earnings: EPS Misses as Pre-Revenue Biotech Continues Development SpendingRetail Earnings Report - dars.gov.et

Jun 05, 2026

Jun 04, 2026

Cocrystal Pharma Appoints James Sapirstein as Chief Executive Officer - Moomoo

Jun 04, 2026

Jun 04, 2026

Cocrystal Pharma taps longtime biotech exec as its new CEO - The Business Journals

Jun 04, 2026

Jun 04, 2026

Cocrystal Pharma Inc. (COCP) Q1 2026 Earnings: Wider-than-expected Loss as R&D Pipeline ProgressesEarnings Whisper Number - newsline.com

Jun 04, 2026

Jun 03, 2026

Cocrystal Pharma (COCP) CEO awarded 235,000 stock options under 2025 plan - Stock Titan

Jun 03, 2026

Jun 03, 2026

Cocrystal Pharma (COCP) CEO James Sapirstein files initial Form 3 - Stock Titan

Jun 03, 2026

Jun 03, 2026

Cocrystal Pharma names James Sapirstein as CEO - The Pharma Letter

Jun 03, 2026

Jun 03, 2026

Cocrystal Pharma Inc. Announces CEO Changes - marketscreener.com

Jun 03, 2026

Jun 03, 2026

Cocrystal Pharma Names New CEO to Drive Antiviral Pipeline - TipRanks

Jun 03, 2026

Jun 03, 2026

Cocrystal Pharma names James Sapirstein as new CEO By Investing.com - Investing.com South Africa

Jun 03, 2026

Jun 03, 2026

Cocrystal Pharma Appoints James Sapirstein, Biopharma Industry Leader with Extensive Antiviral Development Experience, as Chief Executive Officer - BioSpace

Jun 03, 2026

Jun 03, 2026

Cocrystal Pharma names James Sapirstein as new CEO - Investing.com

Jun 03, 2026

Jun 03, 2026

Veteran antiviral leader James Sapirstein to head Cocrystal Pharma (NASDAQ: COCP) - Stock Titan

Jun 03, 2026

Jun 03, 2026

Cocrystal Pharma Appoints James Sapirstein, Biopharma - GlobeNewswire

Jun 03, 2026

Jun 01, 2026

COCP: Presentation Highlights CDI-988 - Zacks Small Cap Research

Jun 01, 2026

May 28, 2026

Analysts Offer Insights on Healthcare Companies: BridgeBio Pharma (BBIO) and Cocrystal Pharma (COCP) - The Globe and Mail

May 28, 2026

May 27, 2026

Noble Financial Maintains Cocrystal Pharma(COCP.US) With Buy Rating, Raises Target Price to $10 - Moomoo

May 27, 2026

May 27, 2026

Cocrystal Pharma (COCP) proxy details board elections, pay and 2026 votes - Stock Titan

May 27, 2026

May 27, 2026

Cocrystal Pharma | 8-K: Current report - Moomoo

May 27, 2026

May 26, 2026

Cocrystal Pharma (COCP) Unveils Promising Antiviral Developments - GuruFocus

May 26, 2026

May 26, 2026

Cocrystal Pharma Reports Promising Pan-Viral Antiviral Activity - TipRanks

May 26, 2026

May 26, 2026

Cocrystal Pharma discovers new pan-viral inhibitors - BioWorld News

May 26, 2026

May 26, 2026

Cocrystal Pharma (NASDAQ: COCP) highlights pan-viral inhibitor data and Phase 1b progress - Stock Titan

May 26, 2026

May 26, 2026

Cocrystal Pharma Announces Discovery of Pan-Viral Inhibitors Targeting Hantavirus, Bunyavirus and Influenza - GlobeNewswire

May 26, 2026

May 23, 2026

COCP Q1 2026 Earnings: Wider Loss Than Expected as Pre-Revenue Biotech Advances PipelineEarnings Revision Upgrade - The Legal Advocate

May 23, 2026

May 21, 2026

Cocrystal Pharma Stock Slips: Why COCP’s Norovirus Bet Is Back in Focus - Bez Kabli

May 21, 2026

May 20, 2026

Cocrystal (COCP) Q1 2026 Earnings Miss by Significant: Key TakeawaysMargin Compression Risk - Newser

May 20, 2026

May 18, 2026

Why Is Cocrystal Pharma, Inc. (COCP) Stock Down Today? - Meyka

May 18, 2026

May 16, 2026

Cocrystal Pharma, Inc. 2026 Q1 Financials: Company Overview, Segment Information, and Going Concern Risks - minichart.com.sg

May 16, 2026

May 15, 2026

Cocrystal (COCP) Declines -3.57% Amid Market Weakness 2026-05-15Market Neutral Pair - newser.com

May 15, 2026

May 15, 2026

Cocrystal Pharma Releases Q1 2026 Financial Results - AlphaStreet

May 15, 2026